Stay updated on Dupilumab in Atopic Hand & Foot Dermatitis Clinical Trial
Sign up to get notified when there's something new on the Dupilumab in Atopic Hand & Foot Dermatitis Clinical Trial page.

Latest updates to the Dupilumab in Atopic Hand & Foot Dermatitis Clinical Trial page
- CheckyesterdayChange DetectedThe clinical trial record for the dupilumab study is displayed, including study methods, participant criteria, outcome measures, results-related record dates, and supporting documents.SummaryDifference75%

- Check7 days agoChange DetectedThe footer revision changes from v3.7.2 to v3.8.0, while the page continues to display a 403 Forbidden error.SummaryDifference0.2%

- Check14 days agoChange DetectedA sitewide NIH notice announces a transition from the term “Artificial Intelligence” to “Super Intelligence” across federal agency content, with both terms potentially appearing during the transition.SummaryDifference1%

- Check21 days agoChange DetectedThe footer’s ClinicalTrials.gov revision identifier changes from v3.7.1 to v3.7.2 on the 403 error page.SummaryDifference0.2%

- Check28 days agoChange DetectedThe footer now identifies the site revision as v3.7.1 instead of v3.7.0.SummaryDifference0.2%

- Check49 days agoChange DetectedA new Revision: v3.7.0 is shown, and a large set of Study Documents entries are removed from the page, reflecting a revision and possible reorganization of available documents for this study.SummaryDifference19%

Stay in the know with updates to Dupilumab in Atopic Hand & Foot Dermatitis Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Dupilumab in Atopic Hand & Foot Dermatitis Clinical Trial page.